BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15546306)

  • 1. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
    Reynolds MR; Joventino LP; Josephson ME;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1513-8. PubMed ID: 15546306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.
    Lecoq G; Leclercq C; Leray E; Crocq C; Alonso C; de Place C; Mabo P; Daubert C
    Eur Heart J; 2005 Jun; 26(11):1094-100. PubMed ID: 15728648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure.
    Berger T; Hanser F; Hintringer F; Poelzl G; Fischer G; Modre R; Tilg B; Pachinger O; Roithinger FX
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):611-7. PubMed ID: 15946359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cardiac resynchronization therapy response.
    Cattadori G; Giraldi F; Berti M; Carbucicchio C; Pepi M; Della Bella P; Contini M; Apostolo A; Berna G; Andreini D; Sciomer S; Agostoni P
    Int J Cardiol; 2009 Aug; 136(2):240-2. PubMed ID: 18672300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy.
    Kronborg MB; Nielsen JC; Mortensen PT
    Europace; 2010 Feb; 12(2):216-22. PubMed ID: 19915182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).
    Kindermann M; Hennen B; Jung J; Geisel J; Böhm M; Fröhlig G
    J Am Coll Cardiol; 2006 May; 47(10):1927-37. PubMed ID: 16697307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study.
    Gasparini M; Bocchiardo M; Lunati M; Ravazzi PA; Santini M; Zardini M; Signorelli S; Passardi M; Klersy C;
    Am Heart J; 2006 Jul; 152(1):155.e1-7. PubMed ID: 16824846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.